UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Laparoscopic-Assisted ERCP in Gastric Bypass Patients—No Stones Left Unturned: A Single Center Retrospective Cohort Study

Obesity surgery, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition

Current medicinal chemistry, 2008-10, Vol.15 (25), p.2559

2008

Link zum Volltext

Verfügbarkeit prüfen

Rational targeting of the urokinase receptor (uPAR): development of antagonists and non-invasive imaging probes

Current drug targets, 2011-11, Vol.12 (12), p.1711

2011

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda

British journal of dermatology (1951), 2015-10, Vol.173 (4), p.1066-1069

2015

Link zum Volltext

Verfügbarkeit prüfen

Peptide-Derived Antagonists of the Urokinase Receptor. Affinity Maturation by Combinatorial Chemistry, Identification of Functional Epitopes, and Inhibitory Effect on Cancer Cell Intravasation

Biochemistry (Easton), 2001-10, Vol.40 (40), p.12157-12168

2001

Link zum Volltext

Verfügbarkeit prüfen

Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPAR

Stem cells (Dayton, Ohio), 1997-01, Vol.15 (6), p.398-408

1997

Link zum Volltext

Verfügbarkeit prüfen

Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor

Current pharmaceutical design, 2003-07, Vol.9 (19), p.1499

Ploug, Michael

2003

Link zum Volltext

Verfügbarkeit prüfen

APOC2 and ANGPTL4 regulate lipoprotein lipase activity by inverse allosteric regulation of its Α/Β–Hydrolase domain

Atherosclerosis, 2023-08, Vol.379, p.S4

2023

Link zum Volltext

Verfügbarkeit prüfen

The Murine Receptor for Urokinase-Type Plasminogen Activator Is Primarily Expressed in Tissues Actively Undergoing Remodeling

The journal of histochemistry and cytochemistry, 2001-02, Vol.49 (2), p.237-246

2001

Link zum Volltext

Verfügbarkeit prüfen

PP 88 C4.4A as a biomarker for poor prognosis in non-small cell lung cancer patients with adenocarcinomas

European journal of cancer (1990), 2011, Vol.47, p.S20-S20

2011

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activation and cancer

Thrombosis and haemostasis, 2005-04, Vol.93 (4), p.676

2005

Link zum Volltext

Verfügbarkeit prüfen

Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins

The Journal of biological chemistry, 1993-08, Vol.268 (23), p.17539-17546

1993

Link zum Volltext

Verfügbarkeit prüfen

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

The Journal of biological chemistry, 1991-01, Vol.266 (3), p.1926-1933

1991

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia

The New England journal of medicine, 2017-04, Vol.376 (17), p.1647-1658

2017

Link zum Volltext

Verfügbarkeit prüfen

Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor: IMPLICATION FOR PRECLINICAL CANCER THERAPY

The Journal of biological chemistry, 2010-04, Vol.285 (14), p.10982-10992

2010

Link zum Volltext

Verfügbarkeit prüfen

Intramolecular Migration of Amide Hydrogens in Protonated Peptides upon Collisional Activation

Journal of the American Chemical Society, 2005-03, Vol.127 (8), p.2785-2793

2005

Link zum Volltext

Verfügbarkeit prüfen

Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide

The EMBO journal, 2005-05, Vol.24 (9), p.1655-1663

2005

Link zum Volltext

Verfügbarkeit prüfen

The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants

The Journal of biological chemistry, 1990-04, Vol.265 (11), p.6453-6460

1990

Link zum Volltext

Verfügbarkeit prüfen

ID: 016 Structural aspects of urokinase-type plasminogen activator receptor (uPAR) function

Journal of thrombosis and haemostasis, 2006-10, Vol.4 (s1), p.25-25

Ploug, M.

2006

Link zum Volltext

Verfügbarkeit prüfen

Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain

The Journal of biological chemistry, 1992-09, Vol.267 (25), p.18224-18229

1992

Link zum Volltext

Verfügbarkeit prüfen

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in pancreatic cancer patients with peritoneal metastasis

HPB (Oxford, England), 2018-09, Vol.20, p.S543-S544

2018

Link zum Volltext

Verfügbarkeit prüfen

The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator

The Journal of biological chemistry, 1991-04, Vol.266 (12), p.7842-7847

1991

Link zum Volltext

Verfügbarkeit prüfen

Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy

Biochemical Society transactions, 2002-04, Vol.30 (2), p.177

2002

Link zum Volltext

Verfügbarkeit prüfen

Identification of Specific Sites Involved in Ligand Binding by Photoaffinity Labeling of the Receptor for the Urokinase-Type Plasminogen Activator. Residues Located at Equivalent Positions in uPAR Domains I and III Participate in the Assembly of a Composite Ligand-Binding Site

Biochemistry (Easton), 1998-11, Vol.37 (47), p.16494-16505

Ploug, Michael

1998

Link zum Volltext

Verfügbarkeit prüfen

The urokinase receptor as a potential target in cancer therapy

Current pharmaceutical design, 2004-07, Vol.10 (19), p.2359

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Life Sciences & Biomedicine
(130)
Humans
(81)
Animals
(67)
Biochemistry & Molecular Biology
(46)
Biological And Medical Sciences
(42)
Male
(35)
Receptors, Urokinase Plasminogen Activator
(35)
Fundamental And Applied Biological Sciences. Psychology
(33)
Urokinase-Type Plasminogen Activator - Metabolism
(29)
Amino Acid Sequence
(28)
Mice
(25)
Molecular Sequence Data
(23)
Rats
(23)
Receptors, Cell Surface - Metabolism
(22)
Cell Biology
(20)
Patient Involvement
(19)
Ecology
(18)
Female
(17)
Endocrinology & Metabolism
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Laparoscopic-Assisted ERCP in Gastric Bypass Patients—No Stones Left Unturned: A Single Center Retrospective Cohort Study

The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition

Rational targeting of the urokinase receptor (uPAR): development of antagonists and non-invasive imaging probes

Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda

Peptide-Derived Antagonists of the Urokinase Receptor. Affinity Maturation by Combinatorial Chemistry, Identification of Functional Epitopes, and Inhibitory Effect on Cancer Cell Intravasation

Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPAR

Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor

APOC2 and ANGPTL4 regulate lipoprotein lipase activity by inverse allosteric regulation of its Α/Β–Hydrolase domain

The Murine Receptor for Urokinase-Type Plasminogen Activator Is Primarily Expressed in Tissues Actively Undergoing Remodeling

PP 88 C4.4A as a biomarker for poor prognosis in non-small cell lung cancer patients with adenocarcinomas

Plasminogen activation and cancer

Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia

Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor: IMPLICATION FOR PRECLINICAL CANCER THERAPY

Intramolecular Migration of Amide Hydrogens in Protonated Peptides upon Collisional Activation

Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide

The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants

ID: 016 Structural aspects of urokinase-type plasminogen activator receptor (uPAR) function

Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in pancreatic cancer patients with peritoneal metastasis

The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator

Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy

Identification of Specific Sites Involved in Ligand Binding by Photoaffinity Labeling of the Receptor for the Urokinase-Type Plasminogen Activator. Residues Located at Equivalent Positions in uPAR Domains I and III Participate in the Assembly of a Composite Ligand-Binding Site

The urokinase receptor as a potential target in cancer therapy

Suchergebnisse filtern